Previous Article | Next Article ![]()
Infection and Immunity, July 1999, p. 3645-3648, Vol. 67, No. 7
Division of Infectious Diseases, Tufts
University School of Veterinary Medicine, North Grafton, Massachusetts
01536
Received 3 March 1999/Returned for modification 5 April
1999/Accepted 13 April 1999
Hemolytic-uremic syndrome (HUS) is a serious disease in children,
attributable in the majority of cases to infection with Shiga toxin
(Stx)-producing Escherichia coli. Using gnotobiotic piglets
orally infected with E. coli O157:H7, which develop
Stx-related cerebellar lesions and fatal neurological symptoms, we show
that administration of Stx2-specific antiserum well after challenge protected, in a dose-response fashion, against these symptoms for at
least 24 h after bacterial challenge. Twenty-six of 30 piglets
given Stx2 antiserum survived the challenge, compared to only 4 of 16 animals given control serum or saline. Given our observations in
piglets, Stx antibody of human origin may likewise prevent HUS in children.
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Antibody-Based Protection of Gnotobiotic Piglets
Infected with Escherichia coli O157:H7 against Systemic
Complications Associated with Shiga Toxin 2
*
Corresponding author. Mailing address: Division of
Infectious Diseases, Tufts University School of Veterinary Medicine,
200 Westboro Road, North Grafton, MA 01536. Phone: (508) 839-7955. Fax:
(508) 839-7977. E-mail: Stzipori{at}infonet.tufts.edu.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|